Selected ticker: AMED.US | View: Annual | Period: 2024-12-31
Line Item
Step Type
Value
Revenue
adjust
$2.35B
Cost of Goods Sold
adjust
$-1.33B
Gross Profit
subtotal
$1.02B
SG&A
adjust
$-790.11M
Other Operating Expense
adjust
$-133.03M
Operating Income
subtotal
$94.54M
Other / Non-Operating Items
adjust
$-51.31M
Net Income
subtotal
$43.23M